Research programme: stem cell therapeutics - Abu Dhabi Stem Cell Center/Pluri
Latest Information Update: 13 Mar 2023
At a glance
- Originator Abu Dhabi Stem Cells Center; Pluristem Therapeutics
- Developer Abu Dhabi Stem Cells Center; Pluri
- Class Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research COVID 2019 infections
Most Recent Events
- 01 Oct 2020 Pluristem Therapeutics and Abu Dhabi Stem Cell Center agree to co-develop stem cell therapies in Israel for COVID-19 infections
- 01 Oct 2020 Early research in COVID-2019 infections in Israel (Inhalation)
- 01 Oct 2020 Early research in COVID-2019 infections in United Arab Emirates (Inhalation)